These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15120709)

  • 1. Pharmacological prevention of diabetic cataract.
    Kyselova Z; Stefek M; Bauer V
    J Diabetes Complications; 2004; 18(2):129-40. PubMed ID: 15120709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pharmacological strategies for the prevention of cataract development.
    Gupta SK; Selvan VK; Agrawal SS; Saxena R
    Indian J Ophthalmol; 2009; 57(3):175-83. PubMed ID: 19384010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
    Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT.
    Kyselova Z; Gajdosik A; Gajdosikova A; Ulicna O; Mihalova D; Karasu C; Stefek M
    Mol Vis; 2005 Jan; 11():56-65. PubMed ID: 15682043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
    Hotta N
    Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye lens in aging and diabetes: effect of quercetin.
    Stefek M; Karasu C
    Rejuvenation Res; 2011 Oct; 14(5):525-34. PubMed ID: 21978083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional antioxidants and age-related cataract and maculopathy.
    Chiu CJ; Taylor A
    Exp Eye Res; 2007 Feb; 84(2):229-45. PubMed ID: 16879819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy: current management and experimental therapeutic targets.
    Ali TK; El-Remessy AB
    Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action.
    Moghaddam MS; Kumar PA; Reddy GB; Ghole VS
    J Ethnopharmacol; 2005 Feb; 97(2):397-403. PubMed ID: 15707781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
    Yatoh S; Mizutani M; Yokoo T; Kozawa T; Sone H; Toyoshima H; Suzuki S; Shimano H; Kawakami Y; Okuda Y; Yamada N
    Diabetes Metab Res Rev; 2006; 22(1):38-45. PubMed ID: 15892182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo.
    Chung YS; Choi YH; Lee SJ; Choi SA; Lee JH; Kim H; Hong EK
    J Ethnopharmacol; 2005 Oct; 101(1-3):49-54. PubMed ID: 15905053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of alpha-crystallin chaperone activity.
    Kumar PA; Reddy PY; Srinivas PN; Reddy GB
    J Nutr Biochem; 2009 Jul; 20(7):553-62. PubMed ID: 18789666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches.
    Costantino L; Rastelli G; Vianello P; Cignarella G; Barlocco D
    Med Res Rev; 1999 Jan; 19(1):3-23. PubMed ID: 9918192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of diabetic retinopathy using functional protein sequences.
    Rao AA; Thota H; Gumpeny RS; Akula A; Changalasetty SB; Challa SR; Ravavarapu T; Akula SP; Divakar Ch; Srinivas K; Das UN
    Med Hypotheses; 2008; 70(1):148-55. PubMed ID: 17548166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.